This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Lignocaine in cardiac resuscitation

Authoring team

Lignocaine is given in stable ventricular tachycardia, or after defibrillation in unstable ventricular tachycardia. It is not an adjunct to defibrillation. Its action is to block re-entry circuits, thus reducing ventricular ectopy.

Points of note include:

  • need to correct hypokalaemia before giving lignocaine
  • doses: see the relevant protocols
  • rapid hepatic elimination and rapid distribution
  • problems in liver disease, CHF or with drugs like cimetidine, propranolol and anticonvulsants.
  • iv access site will be rendered anaesthetic

Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.